External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology JSMO 2022
Roche and Genentech at

JSMO 2022

February 17 - February 19
Tokyo, Japan / Virtual (Hybrid)
c-linkage.co.jp
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:10 PM
Duration 12mins Room 1 (Kyoto International Conference Center 1F Main Hall)
IMpower010: Results From Asian Patients in a Phase 3 Study of Adjuvant Atezolizumab▼ in Resected Stage IB-IIIA NSCLC
Hirotsugu Kenmotsu, Caicun Zhou, Nasser Altorki, Enriqueta Felip, Eric Vallieres, Shunichi Sugawara. Hiroshi Sakai, Haruhiro Saito, Min Tao, Koji Kawaguchi, Yunpeng Liu, Chong-Jen, Yu, Qiong Wu, Lin Huang, Fan Wu, Elizabeth Bennett, Virginia McNally, Barbara Gitlitz, Heather Wakelee
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.